SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-19-000093
Filing Date
2019-01-22
Accepted
2019-01-22 16:28:23
Documents
5
Period of Report
2019-01-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm 8-K 32761
2 EX-10.1 lxrp_ex101.htm EX-10.1 171731
3 EX-10.2 lxrp_ex102.htm EX-10.2 128339
4 EX-10.3 lxrp_ex103.htm EX-10.3 81930
5 EX-10.4 lxrp_ex104.htm EX-10.4 212931
  Complete submission text file 0001640334-19-000093.txt   628945
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 19535635
SIC: 1000 Metal Mining
Assistant Director 9